Edison Oncology Reports Promising Interim Data from Ongoing Orotecan® Clinical Trial for Recurrent Pediatric Cancers Apr 8, 2024 • 10:28am EDT
Edison Oncology Announces Presentation of Two Scientific Posters at AACR Annual Meeting Apr 20, 2023 • 10:09am EDT